These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 26075387)

  • 21. Characterization of IgG N-glycome profile in colorectal cancer progression by MALDI-TOF-MS.
    Liu S; Cheng L; Fu Y; Liu BF; Liu X
    J Proteomics; 2018 Jun; 181():225-237. PubMed ID: 29698801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The identification and characterization of novel N-glycan-based biomarkers in gastric cancer.
    Liu L; Yan B; Huang J; Gu Q; Wang L; Fang M; Jiao J; Yue X
    PLoS One; 2013; 8(10):e77821. PubMed ID: 24147084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contrasting glycosylation profiles between Fab and Fc of a human IgG protein studied by electrospray ionization mass spectrometry.
    Mimura Y; Ashton PR; Takahashi N; Harvey DJ; Jefferis R
    J Immunol Methods; 2007 Sep; 326(1-2):116-26. PubMed ID: 17714731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Healthy human serum N-glycan profiling reveals the influence of ethnic variation on the identified cancer-relevant glycan biomarkers.
    Gebrehiwot AG; Melka DS; Kassaye YM; Rehan IF; Rangappa S; Hinou H; Kamiyama T; Nishimura SI
    PLoS One; 2018; 13(12):e0209515. PubMed ID: 30592755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abnormal glycosylation with hypersialylated O-glycans in patients with Sialuria.
    Wopereis S; Abd Hamid UM; Critchley A; Royle L; Dwek RA; Morava E; Leroy JG; Wilcken B; Lagerwerf AJ; Huijben KM; Lefeber DJ; Rudd PM; Wevers RA
    Biochim Biophys Acta; 2006 Jun; 1762(6):598-607. PubMed ID: 16769205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum sialic acid in patients with multiple myeloma.
    Crook MA; Couchman S; Tutt P
    Br J Biomed Sci; 1996 Sep; 53(3):185-6. PubMed ID: 8914343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Light chain multiple myeloma: an evaluation of its biochemical investigations.
    Zahari Sham SY; C Thambiah S; Samsudin IN; Lim SM
    Malays J Pathol; 2017 Dec; 39(3):311-315. PubMed ID: 29279596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical significance of serum free light chain in patients with multiple myeloma].
    Zhang SS; Wu S; Qu XY; Xu J; Liu P; Lu H; Wu HX; Xu JR; Li JY; Chen LJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Aug; 21(4):930-5. PubMed ID: 23998588
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analytical performance of serum free light-chain assay during monitoring of patients with monoclonal light-chain diseases.
    Tate JR; Mollee P; Dimeski G; Carter AC; Gill D
    Clin Chim Acta; 2007 Feb; 376(1-2):30-6. PubMed ID: 16945362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum free light chain ratio as a biomarker for high-risk smoldering multiple myeloma.
    Larsen JT; Kumar SK; Dispenzieri A; Kyle RA; Katzmann JA; Rajkumar SV
    Leukemia; 2013 Apr; 27(4):941-6. PubMed ID: 23183428
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of glycan variation on glycoproteins from serum by the reverse lectin-based ELISA assay.
    Wu J; Zhu J; Yin H; Buckanovich RJ; Lubman DM
    J Proteome Res; 2014 Apr; 13(4):2197-204. PubMed ID: 24575722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunoglobulin-free light chain monomer-dimer patterns help to distinguish malignant from premalignant monoclonal gammopathies: a pilot study.
    Kaplan B; Golderman S; Aizenbud B; Esev K; Kukuy O; Leiba M; Livneh A; Ben-Zvi I
    Am J Hematol; 2014 Sep; 89(9):882-8. PubMed ID: 24866208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Altered serum N-glycomics in chronic hepatitis B patients.
    Gui HL; Gao CF; Wang H; Liu XE; Xie Q; Dewaele S; Wang L; Zhuang H; Contreras R; Libert C; Chen C
    Liver Int; 2010 Feb; 30(2):259-67. PubMed ID: 19951379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Analysis of monoclonal protein in 72 cases of multiple myeloma].
    Yang JJ; Zhang GS; Chen XR
    Hunan Yi Ke Da Xue Xue Bao; 2001 Apr; 26(2):152-4. PubMed ID: 12536652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic Value of Serum Free Light Chain in Multiple Myeloma.
    El Naggar AA; El-Naggar M; Mokhamer el-H; Avad MW
    Egypt J Immunol; 2015; 22(1):69-78. PubMed ID: 26415374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum free light chains in clinical laboratory diagnostics.
    Jenner E
    Clin Chim Acta; 2014 Jan; 427():15-20. PubMed ID: 23999048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum free light chains for monitoring multiple myeloma.
    Mead GP; Carr-Smith HD; Drayson MT; Morgan GJ; Child JA; Bradwell AR
    Br J Haematol; 2004 Aug; 126(3):348-54. PubMed ID: 15257706
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of N-glycosylation changes in the CSF and serum in patients with schizophrenia.
    Stanta JL; Saldova R; Struwe WB; Byrne JC; Leweke FM; Rothermund M; Rahmoune H; Levin Y; Guest PC; Bahn S; Rudd PM
    J Proteome Res; 2010 Sep; 9(9):4476-89. PubMed ID: 20578731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Breast cancer diagnosis by analysis of serum N-glycans using MALDI-TOF mass spectroscopy.
    Lee SB; Bose S; Ahn SH; Son BH; Ko BS; Kim HJ; Chung IY; Kim J; Lee W; Ko MS; Lee K; Chang S; Park HS; Lee JW; Kim DC
    PLoS One; 2020; 15(4):e0231004. PubMed ID: 32271809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Two year investigation of glycosylation profiles in serum IgG from a patient with multiple myeloma].
    Oita T; Yagi H; Yamashiro A; Sakizono K; Nagai K; Kasakura S; Kato K; Takahashi N
    Rinsho Byori; 2007 Jul; 55(7):626-9. PubMed ID: 17718058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.